Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime S Horton

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncoimmunology|May 7, 2014
The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinomaJaime S Horton, Alexander J Stokes
Channels (Austin, Tex.)|December 11, 2012
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in miceJaime S Horton, Cadie L Buckley, Alexander J Stokes
Annals of the New York Academy of Sciences|May 7, 2009
Identification of relaxin-responsive cells in the human choriodecidua at termJaime S Horton, Sandra Y Yamamoto, Gillian D Bryant-Greenwood
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|March 20, 2014
Relaxin and preterm birthFrederico G Rocha, Jaime S Horton, Gillian D Bryant-Greenwood
Channels (Austin, Tex.)|February 10, 2015
Two-pore channel 1 interacts with citron kinase, regulating completion of cytokinesisJaime S Horton, Clay T Wakano, Mark Speck, et al.
Channels (Austin, Tex.)|October 19, 2013
The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathyJaime S Horton, Cadie L Buckley, Ernest M Alvarez, et al.
Channels (Austin, Tex.)|November 15, 2018
"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure"Jaime S Horton, Takuya Shiraishi, Naghum Alfulaij, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncoimmunology|May 7, 2014
The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinomaJaime S Horton, Alexander J Stokes
Channels (Austin, Tex.)|December 11, 2012
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in miceJaime S Horton, Cadie L Buckley, Alexander J Stokes
Annals of the New York Academy of Sciences|May 7, 2009
Identification of relaxin-responsive cells in the human choriodecidua at termJaime S Horton, Sandra Y Yamamoto, Gillian D Bryant-Greenwood
Italian Journal of Anatomy and Embryology = Archivio Italiano Di Anatomia Ed Embriologia|March 20, 2014
Relaxin and preterm birthFrederico G Rocha, Jaime S Horton, Gillian D Bryant-Greenwood
Channels (Austin, Tex.)|February 10, 2015
Two-pore channel 1 interacts with citron kinase, regulating completion of cytokinesisJaime S Horton, Clay T Wakano, Mark Speck, et al.
Channels (Austin, Tex.)|October 19, 2013
The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathyJaime S Horton, Cadie L Buckley, Ernest M Alvarez, et al.
Channels (Austin, Tex.)|November 15, 2018
"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure"Jaime S Horton, Takuya Shiraishi, Naghum Alfulaij, et al.
Frontiers in Immunology|November 24, 2018
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human PrimatesLiana O Medina, Albert To, Michael M Lieberman, et al.
Pageof 1